Q1 2026 Mirum Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, and welcome to Mirum Pharmaceuticals' first quarter 2026 earnings conference call. My name is Tracy, and I will be your operator today.
All lines are currently in a listen-only mode, and there will be an opportunity for Q&A after management's prepared remarks. If you would like to ask a question during that time, press star one to raise your hand.
I would now like to hand the conference over to Andrew McKibben, SVP of Strategic Finance and Investor Relations. Please go ahead.
Thank you, Tracy, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals' first quarter 2026 earnings conference call. For our prepared remarks, I'm joined today by our Chief Executive Officer, Chris Peetz; President and Chief Operating Officer, Peter Radovich; and Erik Vierkoetter, our Chief Financial Officer. Our Chief Medical Officer, Joanne Quan, will be joining us for Q&A.
Earlier this afternoon, Mirum issued a press release reporting our first
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
